Substratification of stage T1C prostate cancer based on the probability of biochemical recurrence

Cancer Statistics, 2001

2001 • 3,342 citations

Natural History of Progression After PSA Elevation Following Radical Prostatectomy

1999 • 2,993 citations

Pathologic and Clinical Findings to Predict Tumor Extent of Nonpalpable (Stage T1 c) Prostate Cancer

1994 • 1,764 citations

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1997 • 1,621 citations

A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate Cancer

1998 • 1,249 citations

Combination of Prostate-Specific Antigen, Clinical Stage, and Gleason Score to Predict Pathological Stage of Localized Prostate Cancer

1997 • 1,140 citations

Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium

2001 • 1,052 citations

LONG-TERM BIOCHEMICAL DISEASE-FREE AND CANCER-SPECIFIC SURVIVAL FOLLOWING ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY

2001 • 1,022 citations

PROSTATE SPECIFIC ANTIGEN: A DECADE OF DISCOVERY-WHAT WE HAVE LEARNED AND WHERE WE ARE GOING

1999 • 618 citations

The Value of Serum Prostate Specific Antigen Determinations Before and after Radical Prostatectomy

1989 • 534 citations

Clinical Utility of the Percentage of Positive Prostate Biopsies in Defining Biochemical Outcome After Radical Prostatectomy for Patients With Clinically Localized Prostate Cancer

2000 • 291 citations

ERA SPECIFIC BIOCHEMICAL RECURRENCE-FREE SURVIVAL FOLLOWING RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER

2001 • 282 citations

Is Prostate Specific Antigen of Clinical Importance in Evaluating Outcome after Radical Prostatectomy

1993 • 240 citations

State T1–2 prostate cancer: A multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy

1997 • 214 citations

Results of radical prostatectomy in men with clinically localized prostate cancer.

1996 • 206 citations

Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy

1995 • 191 citations

Analysis of Risk Factors for Progression in Patients with Pathologically Confined Prostate Cancers After Radical Retropubic Prostatectomy

1996 • 175 citations

VALIDATION OF PARTIN TABLES FOR PREDICTING PATHOLOGICAL STAGE OF CLINICALLY LOCALIZED PROSTATE CANCER

2000 • 174 citations

Radical prostatectomy for adenocarcinoma of the prostate: The influence of preoperative and pathologic findings on biochemical disease-free outcome

1994 • 173 citations

PREDICTING PROSTATE SPECIFIC ANTIGEN OUTCOME PREOPERATIVELY IN THE PROSTATE SPECIFIC ANTIGEN ERA

2001 • 165 citations

PERCENT PROSTATE NEEDLE BIOPSY TISSUE WITH CANCER IS MORE PREDICTIVE OF BIOCHEMICAL FAILURE OR ADVERSE PATHOLOGY AFTER RADICAL PROSTATECTOMY THAN PROSTATE SPECIFIC ANTIGEN OR GLEASON SCORE

2002 • 142 citations

Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer

1997 • 134 citations

Results of Radical Prostatectomy in Men With Clinically Localized Prostate Cancer

1996 • 125 citations

OUTCOME BASED STAGING FOR CLINICALLY LOCALIZED ADENOCARCINOMA OF THE PROSTATE

1997 • 102 citations

Biostatistical modeling using traditional variables and genetic biomarkers for predicting the risk of prostate carcinoma recurrence after radical prostatectomy

1997 • 81 citations

Salvage radical prostatectomy for adenocarcinoma of the prostate

1988 • 77 citations

Combined-modality staging for localized adenocarcinoma of the prostate.

2001 • 65 citations

Bilateral Pelvic Lymphadenectomy and Radical Retropubic Prostatectomy for Adenocarcinoma Confined to the Prostate

1984 • 53 citations

Recursive partitioning for prognostic grouping of patients with clinically localized prostate carcinoma

2000 • 26 citations

ROC optimization may improve risk stratification of prostate cancer patients

2001 • 18 citations